Parsippany, NJ, United States of America

Angelo Secci

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2012.

USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angelo Secci: Pioneering Inventor from Parsippany, NJ

Introduction: Angelo Secci is a renowned inventor hailing from Parsippany, New Jersey. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Angelo Secci holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His recent patents focus on enhancing user experience in digital platforms and improving sustainability practices in the energy sector.

Career Highlights: Throughout his illustrious career, Angelo Secci has worked with leading tech companies to bring his inventions to life. His innovative solutions have garnered recognition for their impact on improving efficiency and driving progress in the industry.

Collaborations: Angelo Secci has collaborated with top researchers, engineers, and designers to push the boundaries of technological advancement. His partnerships with industry experts have led to the development of cutting-edge products that have revolutionized the way we interact with technology.

Conclusion: Angelo Secci's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…